Research to Prevent Blindness

Macular Degeneration, Diabetic Retinopathy Reversed

Dr. Zhang.jpg

Dr. Kang Zhang, MD, PhD, Associate Professor and an RPB Lew R. Wasserman Merit Awardee at the University of Utah, John A. Moran Eye Center uses a state-of-the-art genetic analyzer to accelerate the discovery of genes involved in blinding eye diseases.

Two leading causes of blindness can be reversed or even prevented by drugs that activate a protein found in blood vessel cells. The discovery is an example of basic science research yielding a discovery with direct clinical applications.

Related News: Diabetic Retinopathy

RPB Presents Scientists at the Frontiers of Retinal Research

At the ARVO Inaugural Press Conference, three RPB-funded scientists pushing the boundaries of imaging, early detection, regeneration.

Read More


Alternative Treatment for Diabetic Retinopathy

RPB-supported commentary on approaches to using the anti-VEGF therapy.

Read More


New Retinal Disease Discovered

RPB-supported researchers have found a new, rare inherited retinal disease. The  investigators hope that finding the genetic cause will increase understanding of more common retinal diseases. The macula,...

Read More


New Vision Screening Device Provides Early Warning of Diabetic Eye Disease

RPB-supported research yields test that could give doctors and patients  a head start on treating diabetes and...

Read More



Get our email updates filled with the latest news from our researchers about preventing vision loss, treating eye disease and even restoring sight. Unsubscribe at any time. Under our privacy policy, we'll never share your contact information with a third party.